Physician profile
Timothy Murphy
NPI 1467847061
$3,398.81
in general payments reported to CMS, 2019-2025
8 companies · $2,304 in 2025
The $2,304 reported for 2025 was more than what 82% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,095 · 2025: $2,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,937 · Food and Beverage: $1,241 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,937.06 |
| Food and Beverage | $1,241.08 |
| Education | $220.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,450.93 | 2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,236.18 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Spr Therapeutics, INC | $550.03 | 2025 | Sprint Pns System |
| Abbvie INC. | $66.11 | 2025 | |
| Nalu Medical, INC. | $27.57 | 2025 | Nalu Neurostimulation System |
| Azurity Pharmaceuticals, INC. | $27.07 | 2025 | Horizant |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.19 | 2025 | Relistor |
| Collegium Pharmaceutical, INC. | $17.73 | 2025 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.